Related Experiment Video
Updated: Mar 19, 2026
![Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62460.jpg&w=3840&q=50)
Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging
Published on: July 1, 2021
Cannabinoid Receptor 2 as Antiobesity Target: Inflammation, Fat Storage, and Browning Modulation
Francesca Rossi1, Giulia Bellini1, Livio Luongo1
1Department of Women, Child and General and Specialist Surgery (F.R., I.M., A.G., B.N., L.P., E.M.d.G.) and Department of Experimental Medicine (G.B., L.L., I.M., C.T., S.M.), Division of Pharmacology Leonardo Donatelli, The Second University of Naples, 80138 Naples, Italy; The Endocannabinoid Research Group (L.L., S.M.), 80078 Pozzuoli, Naples, Italy; Division of General and Obesity Surgery (S.T., L.D.), The Second University of Naples, 80131 Naples, Italy; Department of Onco-Hematology (M.E.B., A.C., F.L.), Istituto di Ricovero e Cura a Caarattere Scientifico Bambino Gesù Children's Hospital, 00165 Rome, Italy; and University of Pavia (F.L.), 27100 Pavia, Italy.
Context:
Obesity is associated with a low-grade inflammatory state and adipocyte (ADP) hyperplasia/hypertrophy. Obesity inhibits the "browning" of white adipose tissue. Cannabinoid receptor 2 (CB2) agonists reduce food intake and induce antiobesity effect in mice. A common missense CB2 variant, Q63R, causes CB2-reduced function.
Objective:
To evaluate the influence of CB2 receptor on the modulation of childhood obesity and of ADP activity and morphology.
Design:
CB2-Q63R variant was analyzed in obese Italian children. The effects of an inflammatory stimulus and those of drugs selectively acting on CB2 were investigated on in vitro ADPs obtained from mesenchymal stem cells of adult healthy donors or from sc adipose biopsies of adult nonobese and obese subjects.
Setting:
Department of Women, Child and General and Specialist Surgery of the Second University of Naples.
Patients Or Other Participants:
A total of 501 obese Italian children (age 11 ± 2.75). Twelve healthy bone marrow donors (age 36.5 ± 15); and 17 subjects, 7 lean (age 42 ± 10) and 10 obese (age 37.8 ± 12) underwent sc adipose tissue biopsies.
Main Outcome Measures:
Effects of CB2 stimulation on adipokine, perilipin, and uncoupling protein-1 expression.
Results:
The less-functional CB2-R63 variant was significantly associated with a high z-score body mass index. CB2 blockade with AM630 reverse agonist increased inflammatory adipokine release and fat storage and reduced browning. CB2 stimulation with JWH-133 agonist reversed all of the obesity-related effects.
Conclusion:
CB2 receptor is a novel pharmacological target that should be considered for obesity.
Insights
The less-functional CB2-R63 variant is linked to childhood obesity. Targeting the CB2 receptor may offer a new therapeutic strategy for managing obesity and its associated inflammatory effects.
Area of Science:
- Endocrinology and Metabolism
- Molecular Biology
- Genetics
Background:
- Obesity is linked to low-grade inflammation and altered adipose tissue (ADP) characteristics.
- The Cannabinoid Receptor 2 (CB2) plays a role in regulating food intake and has shown anti-obesity effects in animal models.
- A specific variant, CB2-Q63R, is associated with reduced CB2 receptor function.
Purpose of the Study:
- To investigate the impact of the CB2 receptor on childhood obesity.
- To analyze the influence of CB2 receptor modulation on adipocyte activity and morphology.
- To assess the role of the CB2-Q63R variant in obese children.
Main Methods:
- Analysis of the CB2-Q63R variant in 501 obese Italian children.
- In vitro studies using adipocytes derived from mesenchymal stem cells and adipose tissue biopsies from lean and obese adults.
- Investigation of inflammatory stimuli and selective CB2 receptor agonists/antagonists (AM630, JWH-133) effects on adipocytes.
Main Results:
- The less-functional CB2-R63 variant showed a significant association with higher body mass index z-scores in children.
- CB2 receptor blockade increased inflammatory adipokine release, fat storage, and reduced adipose tissue browning.
- CB2 receptor stimulation with JWH-133 reversed obesity-related effects, including increased browning and reduced inflammation.
Conclusions:
- The CB2 receptor is a potential pharmacological target for obesity treatment.
- Modulating CB2 receptor activity can influence adipocyte function, inflammation, and energy metabolism.
- The CB2-Q63R variant may contribute to the pathophysiology of obesity.
Related Concept Videos
Regulation of Food Intake
Obesity
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...

